Werner Spinner, a non-executive director at the stem cell bank group Cryo-Save, has topped up his stake in the company, taking about £20,000 worth of shares.
Spinner, who served for 30 years with the German drug giant Bayer, took 25,000 shares at 77.2p a time.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Cryo-Save, which has its headquarters in the Netherlands and stores more than 100,000 adult stem cells in storage facilities in Belgium, Germany and Dubai, last month reported a fall in full-year profits due to higher operating expenses, but said it was well positioned to capitalise on its international position.
Revenue was up 67% to €29.5m in the year ended 31 December, while pre-tax profit fell to €2.86m compared with €4.51m last time as operating expenses rose to €17.9m from €7.13m previously.
Top Director Buys
Value: £49,980
Value: £19,740
Value: £19,300
Value: $12,000
Value: £10,183
Top Director Sells
Value: £2,400,000
Value: £2,400,000
Value: £960,000
Value: £321,922
Value: £119,138
Value: £53,472
Value: £41,736
Value: £38,244
Value: £35,123
Value: £12,000
-
Inheritance tax pension reforms will delay payments to grieving families and the taxmanThe government is pressing ahead with plans to charge inheritance tax on pensions but there are warnings that it will be harder for executors to administer an estate and pay HMRC
-
More than a million pensioners set to be hit by tax on savings accountsA combination of higher interest rates and frozen tax thresholds is dragging more people into paying tax on their cash savings
